
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Investigation of COVID-19 comorbidities reveals genes and pathways coincident with the SARS-CoV-2 viral disease
M. Eileen Dolan, David P. Hill, Gaurab Mukherjee, et al.
Scientific Reports (2020) Vol. 10, Iss. 1
Open Access | Times Cited: 45
M. Eileen Dolan, David P. Hill, Gaurab Mukherjee, et al.
Scientific Reports (2020) Vol. 10, Iss. 1
Open Access | Times Cited: 45
Showing 1-25 of 45 citing articles:
Inflammasome activation in infected macrophages drives COVID-19 pathology
Esen Sefik, Rihao Qu, Caroline Junqueira, et al.
Nature (2022) Vol. 606, Iss. 7914, pp. 585-593
Open Access | Times Cited: 422
Esen Sefik, Rihao Qu, Caroline Junqueira, et al.
Nature (2022) Vol. 606, Iss. 7914, pp. 585-593
Open Access | Times Cited: 422
Bioinformatics and machine learning approach identifies potential drug targets and pathways in COVID-19
Md. Rabiul Auwul, Md Rezanur Rahman, Esra Göv, et al.
Briefings in Bioinformatics (2021) Vol. 22, Iss. 5
Open Access | Times Cited: 95
Md. Rabiul Auwul, Md Rezanur Rahman, Esra Göv, et al.
Briefings in Bioinformatics (2021) Vol. 22, Iss. 5
Open Access | Times Cited: 95
A humanized mouse model of chronic COVID-19
Esen Sefik, Benjamin Israelow, Haris Mirza, et al.
Nature Biotechnology (2021) Vol. 40, Iss. 6, pp. 906-920
Open Access | Times Cited: 94
Esen Sefik, Benjamin Israelow, Haris Mirza, et al.
Nature Biotechnology (2021) Vol. 40, Iss. 6, pp. 906-920
Open Access | Times Cited: 94
A meta-analysis of comorbidities in COVID-19: Which diseases increase the susceptibility of SARS-CoV-2 infection?
Manoj Kumar Singh, Ahmed Mobeen, Amit Chandra, et al.
Computers in Biology and Medicine (2021) Vol. 130, pp. 104219-104219
Open Access | Times Cited: 82
Manoj Kumar Singh, Ahmed Mobeen, Amit Chandra, et al.
Computers in Biology and Medicine (2021) Vol. 130, pp. 104219-104219
Open Access | Times Cited: 82
Mutations in SARS-CoV-2 structural proteins: a global analysis
Mohammad Abavisani, Karim Rahimian, Bahar Mahdavi, et al.
Virology Journal (2022) Vol. 19, Iss. 1
Open Access | Times Cited: 57
Mohammad Abavisani, Karim Rahimian, Bahar Mahdavi, et al.
Virology Journal (2022) Vol. 19, Iss. 1
Open Access | Times Cited: 57
Differential Co-Expression Network Analysis Reveals Key Hub-High Traffic Genes as Potential Therapeutic Targets for COVID-19 Pandemic
Aliakbar Hasankhani, Abolfazl Bahrami, Negin Sheybani, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 51
Aliakbar Hasankhani, Abolfazl Bahrami, Negin Sheybani, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 51
Causal associations and shared genetics between hypertension and COVID‐19
Ancha Baranova, Hongbao Cao, Fuquan Zhang
Journal of Medical Virology (2023) Vol. 95, Iss. 4
Closed Access | Times Cited: 20
Ancha Baranova, Hongbao Cao, Fuquan Zhang
Journal of Medical Virology (2023) Vol. 95, Iss. 4
Closed Access | Times Cited: 20
A Journey into the Clinical Relevance of Heme Oxygenase 1 for Human Inflammatory Disease and Viral Clearance: Why Does It Matter on the COVID-19 Scene?
Ayelén Toro, María Sol Ruiz, Sofía Lage-Vickers, et al.
Antioxidants (2022) Vol. 11, Iss. 2, pp. 276-276
Open Access | Times Cited: 23
Ayelén Toro, María Sol Ruiz, Sofía Lage-Vickers, et al.
Antioxidants (2022) Vol. 11, Iss. 2, pp. 276-276
Open Access | Times Cited: 23
Identification of Comorbidities, Genomic Associations, and Molecular Mechanisms for COVID-19 Using Bioinformatics Approaches
Shudeb Babu Sen Omit, Salma Akhter, Humayan Kabir Rana, et al.
BioMed Research International (2023) Vol. 2023, pp. 1-24
Open Access | Times Cited: 12
Shudeb Babu Sen Omit, Salma Akhter, Humayan Kabir Rana, et al.
BioMed Research International (2023) Vol. 2023, pp. 1-24
Open Access | Times Cited: 12
A comprehensive investigation on the receptor BSG expression reveals the potential risk of healthy individuals and cancer patients to 2019-nCoV infection
Yongbiao Huang, Haiting Zhou, Yuan Wang, et al.
Aging (2024) Vol. 16, Iss. 6, pp. 5412-5434
Open Access | Times Cited: 3
Yongbiao Huang, Haiting Zhou, Yuan Wang, et al.
Aging (2024) Vol. 16, Iss. 6, pp. 5412-5434
Open Access | Times Cited: 3
Unraveling the molecular crosstalk between Atherosclerosis and COVID-19 comorbidity
Deepyaman Das, Soumita Podder
Computers in Biology and Medicine (2021) Vol. 134, pp. 104459-104459
Open Access | Times Cited: 23
Deepyaman Das, Soumita Podder
Computers in Biology and Medicine (2021) Vol. 134, pp. 104459-104459
Open Access | Times Cited: 23
Comprehensive analysis of pathways in Coronavirus 2019 (COVID-19) using an unsupervised machine learning method
Golnaz Taheri, Mahnaz Habibi
Applied Soft Computing (2022) Vol. 128, pp. 109510-109510
Open Access | Times Cited: 16
Golnaz Taheri, Mahnaz Habibi
Applied Soft Computing (2022) Vol. 128, pp. 109510-109510
Open Access | Times Cited: 16
Towards AI-Enabled Multimodal Diagnostics and Management of COVID-19 and Comorbidities in Resource-Limited Settings
Olawande Daramola, Peter Nyasulu, Tivani P. Mashamba-Thompson, et al.
Informatics (2021) Vol. 8, Iss. 4, pp. 63-63
Open Access | Times Cited: 21
Olawande Daramola, Peter Nyasulu, Tivani P. Mashamba-Thompson, et al.
Informatics (2021) Vol. 8, Iss. 4, pp. 63-63
Open Access | Times Cited: 21
Inflammasome activation in infected macrophages drives COVID-19 pathology
Esen Sefik, Rihao Qu, Caroline Junqueira, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 20
Esen Sefik, Rihao Qu, Caroline Junqueira, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 20
SERPINE1 rs6092 Variant Is Related to Plasma Coagulation Proteins in Patients with Severe COVID-19 from a Tertiary Care Hospital
Ingrid Fricke-Galindo, Ivette Buendía-Roldán, Leslie Chávez‐Galán, et al.
Biology (2022) Vol. 11, Iss. 4, pp. 595-595
Open Access | Times Cited: 14
Ingrid Fricke-Galindo, Ivette Buendía-Roldán, Leslie Chávez‐Galán, et al.
Biology (2022) Vol. 11, Iss. 4, pp. 595-595
Open Access | Times Cited: 14
A humanized mouse model of chronic COVID-19 to evaluate disease mechanisms and treatment options
Esen Sefik, Ben Israelow, Jun Zhao, et al.
Research Square (Research Square) (2021)
Open Access | Times Cited: 14
Esen Sefik, Ben Israelow, Jun Zhao, et al.
Research Square (Research Square) (2021)
Open Access | Times Cited: 14
Postcovid syndrome — polymorphism of disorders in a new coronavirus infection
N. А. Belyakov, T. N. Trofimova, В. В. Рассохин, et al.
HIV Infection and Immunosuppressive Disorders (2022) Vol. 13, Iss. 4, pp. 7-20
Open Access | Times Cited: 10
N. А. Belyakov, T. N. Trofimova, В. В. Рассохин, et al.
HIV Infection and Immunosuppressive Disorders (2022) Vol. 13, Iss. 4, pp. 7-20
Open Access | Times Cited: 10
The roles of cellular protease interactions in viral infections and programmed cell death: a lesson learned from the SARS-CoV-2 outbreak and COVID-19 pandemic
Martyna Majchrzak, Marcin Poręba
Pharmacological Reports (2022) Vol. 74, Iss. 6, pp. 1149-1165
Open Access | Times Cited: 10
Martyna Majchrzak, Marcin Poręba
Pharmacological Reports (2022) Vol. 74, Iss. 6, pp. 1149-1165
Open Access | Times Cited: 10
A SARS-CoV-2 (COVID-19) biological network to find targets for drug repurposing
Mahnaz Habibi, Golnaz Taheri, Rosa Aghdam
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 11
Mahnaz Habibi, Golnaz Taheri, Rosa Aghdam
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 11
Serum Proteomic Analysis for New Types of Long-Term Persistent COVID-19 Patients in Wuhan
Cuidan Li, Liya Yue, Yingjiao Ju, et al.
Microbiology Spectrum (2022) Vol. 10, Iss. 6
Open Access | Times Cited: 7
Cuidan Li, Liya Yue, Yingjiao Ju, et al.
Microbiology Spectrum (2022) Vol. 10, Iss. 6
Open Access | Times Cited: 7
Deregulation of ceRNA Networks in Frontal Cortex and Choroid Plexus of Brain during SARS‐CoV‐2 Infection Aggravates Neurological Manifestations: An Insight from Bulk and Single‐Cell Transcriptomic Analyses
Deepyaman Das, Soumita Podder
Advanced Biology (2022) Vol. 6, Iss. 8
Open Access | Times Cited: 4
Deepyaman Das, Soumita Podder
Advanced Biology (2022) Vol. 6, Iss. 8
Open Access | Times Cited: 4
Stratifying risk outcomes among adult COVID-19 inpatients with high flow oxygen: The R4 score
Gloria Mayela Aguirre-García, Diego Ramonfaur, Guillermo Torre‐Amione, et al.
Pulmonology (2021) Vol. 29, Iss. 3, pp. 200-206
Open Access | Times Cited: 5
Gloria Mayela Aguirre-García, Diego Ramonfaur, Guillermo Torre‐Amione, et al.
Pulmonology (2021) Vol. 29, Iss. 3, pp. 200-206
Open Access | Times Cited: 5
Computational and Bioinformatics Approaches for Identifying Comorbidities of COVID-19 Using Transcriptomic Data
Shudeb Babu Sen Omit, Md. Mohiuddin, Salma Akhter, et al.
Journal of Engineering Research and Sciences (2024) Vol. 3, Iss. 4, pp. 32-41
Open Access
Shudeb Babu Sen Omit, Md. Mohiuddin, Salma Akhter, et al.
Journal of Engineering Research and Sciences (2024) Vol. 3, Iss. 4, pp. 32-41
Open Access
Metabolomic Approach to Identify the Potential Metabolites from Alpinia malaccensis for Treating SARS-CoV-2 Infection
Esrat Jahan, Tanoy Mazumder, Tarek Hasan, et al.
Biochemical Genetics (2024)
Closed Access
Esrat Jahan, Tanoy Mazumder, Tarek Hasan, et al.
Biochemical Genetics (2024)
Closed Access
Systems biology models to identify the influence of SARS-CoV-2 infections to the progression of human autoimmune diseases
Md. Al-Mustanjid, Sakib Mahmud, Farzana Akter, et al.
Informatics in Medicine Unlocked (2022) Vol. 32, pp. 101003-101003
Open Access | Times Cited: 3
Md. Al-Mustanjid, Sakib Mahmud, Farzana Akter, et al.
Informatics in Medicine Unlocked (2022) Vol. 32, pp. 101003-101003
Open Access | Times Cited: 3